Do you want to read an article? Please log in or register.
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
COVID-19
Related content
RECOMMENDED
COVID-19
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur J Cancer
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C
doi: 10.1016/j.ejca.2021.10.014
COVID-19
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
Ann Rheum Dis
Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z
doi: 10.1136/annrheumdis-2021-221097
COVID-19Cardiovascular
COVID-19 et maladies cardiovasculaires : une association à double sens
healthbook TIMES
COVID-19
Pandémie de COVID-19 : un défi et une chance pour la santé mentale de la population
healthbook TIMES
Ophthalmology
Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials
Arthritis Res Ther
Roche D, Badard M, Boyer L, Lafforgue P, Pham T
doi: 10.1186/s13075-021-02549-0
Neurology · Psychiatry
Sclérose en plaques : des progrès dans le traitement modifiant le cours de la maladie
healthbook TIMES
COVID-19
Association of the Delta (B.1.617.2) Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) With Pregnancy Outcomes
Obstet Gynecol
Wang AM, Berry M, Moutos CP, Omere C, Clark SM, Harirah HM, Jain S, Olson GL, Pacheco LD, Saade GR, Saad AF
doi: 10.1097/AOG.0000000000004595
COVID-19
Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant
Obstet Gynecol
Seasely AR, Blanchard CT, Arora N, Battarbee AN, Casey BM, Dionne-Odom J, Sinkey RG, Szychowski JM, Tita AT, Subramaniam A, CWRH COVID-19 Working Group.
doi: 10.1097/AOG.0000000000004607
Diabetes + Endocrinology
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Lancet
Ludvik B, Giorgino F, Jódar E, Frias JP, Fernández Landó L, Brown K, Bray R, Rodríguez Á
doi: 10.1016/S0140-6736(21)01443-4